Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BIO-key InternationalBKYI -4.76%42 Debt-to-Equity is 0.20 as of Jun. 2026, which is 54% above its 10-year median of 0.13. GuruFocus rates BKYI with a GF Score™ of 42/100 and a GF Value™ of $2.32 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 952 Business Services companies, BIO-key International ranks better than 60.92% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for BIO-key International's Debt-to-Equity or its related term are showing as below:
BKYI'
s Debt-to-Equity Range Over the Past 10 Years
Min: -2.15 Med: 0.13 Max: 18.53
Current: 0.2
During the past 13 years, the highest Debt-to-Equity Ratio of BIO-key International was 18.53. The lowest was -2.15. And the median was 0.13.
BKYI's Debt-to-Equity is ranked better than 60.92% of 952
companies
in the Business Services industry
Industry Median: 0.34
vs BKYI: 0.20
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
BIO-key International Debt-to-Equity Related Terms
BIO-key International Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for BIO-key International's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKYI vs IVDA, AGSS, IWAL: Debt-to-Equity Comparison
For the Security & Protection Services subindustry, BIO-key International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BIO-key International Debt-to-Equity vs Business Services Industry
For the Business Services industry and Industrials sector, BIO-key International's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where BIO-key International's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIO-key International (BKYI) has a Debt-to-Equity of 0.20 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BIO-key International and its competitors. This is 54% above median its historical median of 0.13. According to the industry distribution chart, BIO-key International ranks #372 out of 952 companies in the Business Services industry, placing it in the top 39.1%.
Is BIO-key International's Debt-to-Equity too high?
BIO-key International's current Debt-to-Equity of 0.20 is 54% above median its 10-year median of 0.13. The Business Services industry median Debt-to-Equity is 0.34. BIO-key International's value of 0.20 is 41.2% below this industry median. Based on the distribution chart, BIO-key International ranks #372 out of 952 companies in the Business Services industry, which is above the industry midpoint. Overall, BIO-key International has a GF Score™ of 42/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BIO-key International's Debt-to-Equity compare to IVDA and AGSS?
According to the Business Services industry distribution chart, BIO-key International ranks #372 out of 952 companies for Debt-to-Equity. This puts BIO-key International in the upper half of its industry. The industry median Debt-to-Equity is 0.34. BIO-key International's value of 0.20 is 41.2% below this benchmark. While the company's 10-year median is 0.13 vs. the industry median of 0.34, BIO-key International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Business Services company?
The median Debt-to-Equity among Business Services companies is 0.34, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BIO-key International's current Debt-to-Equity of 0.20 is 41.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BIO-key International and its competitors. For the Business Services industry, the median Debt-to-Equity is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BIO-key International's current Debt-to-Equity is 0.20, which is 54% above median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BIO-key International stock overvalued right now?
Based on GuruFocus' analysis, BIO-key International (BKYI) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.32, compared to a current price of $2.80 — trading 20.7% above its estimated fair value. The current Debt-to-Equity is 0.20, which is 54% above median its 10-year median of 0.13 and 41.2% below the Business Services industry median of 0.34. BIO-key International's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For BIO-key International (BKYI), the current Debt-to-Equity is 0.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BIO-key International (BKYI) Overvalued in 2026?
Based on GuruFocus' analysis, BIO-key International stock appears to be overvalued.
The current stock price of $2.80 is trading 20.7% above its estimated GF Value™ of $2.32.
GuruFocus considers BIO-key International to be Modestly Overvalued.
Key valuation signals for BKYI:
Debt-to-Equity: 0.20 (54% above median its 10-year median of 0.13)
GF Value™: $2.32 vs. price of $2.80 (20.7% above fair value)
Industry Position: 41.2% below the Business Services median (#372 of 952)
No single metric tells the full story. See the BKYI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
42GF Score
Get the complete analysis for BKYI
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKYI has been successfully added to your 
